These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27467876)

  • 21. Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.
    Yan A; Wang K
    Bioorg Med Chem Lett; 2012 May; 22(9):3336-42. PubMed ID: 22460031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
    Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
    J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.
    Wang M; Zhong M; Yan A; Li L; Yu C
    SAR QSAR Environ Res; 2014; 25(1):1-15. PubMed ID: 24283437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of bioactivity of ACAT2 inhibitors by multilinear regression analysis and support vector machine.
    Zhong M; Xuan S; Wang L; Hou X; Wang M; Yan A; Dai B
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3788-92. PubMed ID: 23711921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Support Vector Machine (SVM) Models for Predicting Inhibitors of the 3' Processing Step of HIV-1 Integrase.
    Xuan S; Wang M; Kang H; Kirchmair J; Tan L; Yan A
    Mol Inform; 2013 Oct; 32(9-10):811-26. PubMed ID: 27480234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Non-Parametric Approach for the Activation Detection of Block Design fMRI Simulated Data Using Self-Organizing Maps and Support Vector Machine.
    Bahrami S; Shamsi M
    J Med Signals Sens; 2017; 7(3):153-162. PubMed ID: 28840116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarity perception of reactions catalyzed by oxidoreductases and hydrolases using different classification methods.
    Hu X; Yan A; Tan T; Sacher O; Gasteiger J
    J Chem Inf Model; 2010 Jun; 50(6):1089-100. PubMed ID: 20515020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of chemical carcinogenicity by machine learning approaches.
    Tan NX; Rao HB; Li ZR; Li XY
    SAR QSAR Environ Res; 2009; 20(1-2):27-75. PubMed ID: 19343583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and control of dynamical systems using the self-organizing map.
    Barreto GA; Araujo AR
    IEEE Trans Neural Netw; 2004 Sep; 15(5):1244-59. PubMed ID: 18238091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automatic detection and classification of abnormalities for artificial hearts using a hierarchical self-organizing map.
    Wang XZ; Yoshizawa M; Tanaka A; Abe K; Yambe T; Nitta S
    Artif Organs; 2001 Feb; 25(2):150-3. PubMed ID: 11251481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of acetylcholinesterase inhibitors and decoys by a support vector machine.
    Wang K; Hu X; Wang Z; Yan A
    Comb Chem High Throughput Screen; 2012 Jul; 15(6):492-502. PubMed ID: 22263859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of support vector machine and artificial neural network systems for drug/nondrug classification.
    Byvatov E; Fechner U; Sadowski J; Schneider G
    J Chem Inf Comput Sci; 2003; 43(6):1882-9. PubMed ID: 14632437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
    Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
    Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of Meta-Parameters for Support Vector Machine Linear Combinations.
    Jasial S; Balfer J; Vogt M; Bajorath J
    Mol Inform; 2015 Feb; 34(2-3):127-33. PubMed ID: 27490035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand Based Virtual Screening Using Self-organizing Maps.
    Jayaraj PB; Sanjay S; Raja K; Gopakumar G; Jaleel UC
    Protein J; 2022 Feb; 41(1):44-54. PubMed ID: 35022993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust support vector machine-trained fuzzy system.
    Forghani Y; Yazdi HS
    Neural Netw; 2014 Feb; 50():154-65. PubMed ID: 24316676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug/nondrug classification using Support Vector Machines with various feature selection strategies.
    Korkmaz S; Zararsiz G; Goksuluk D
    Comput Methods Programs Biomed; 2014 Nov; 117(2):51-60. PubMed ID: 25224081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening of molecular databases using a support vector machine.
    Jorissen RN; Gilson MK
    J Chem Inf Model; 2005; 45(3):549-61. PubMed ID: 15921445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors.
    Zhang H; Xiang ML; Zhao YL; Wei YQ; Yang SY
    Eur J Pharm Sci; 2009 Mar; 36(4-5):451-7. PubMed ID: 19124075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.